# Implantation or Injectable Dosage Form New Animal Drugs; Amikacin Sulfate Injection
> **Food and Drug Administration** · Final rule. · Published 1997-04-30 · Effective 1997-04-30 · 62 FR 23357
## Document
- **Document number:** 97-11085
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 62 FR 23357
- **CFR reference:** 21 CFR 522
- **Publication date:** 1997-04-30
- **Effective date:** 1997-04-30
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Phoenix Scientific, Inc. The ANADA provides for the use of amikacin sulfate injection for the treatment of the following conditions in dogs: genitourinary tract infections (cystitis) caused by susceptible strains of Escherichia coli and Proteus spp. and skin and soft tissue infections caused by susceptible strains of Pseudomonas spp. and E. coli.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1997/04/30/97-11085/implantation-or-injectable-dosage-form-new-animal-drugs-amikacin-sulfate-injection)
---
*AI Analytics · CC0 1.0*